US Stock MarketDetailed Quotes

IRON Disc Medicine

Watchlist
  • 45.400
  • -0.790-1.71%
Close Jul 19 16:00 ET
  • 45.400
  • 0.0000.00%
Post 16:20 ET
1.35BMarket Cap-13716P/E (TTM)

Disc Medicine Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
5.26%-33.6M
-73.87%-73.46M
-84.13%-17.8M
22.86%-7.48M
-38.39%-12.72M
-158.86%-35.47M
-53.45%-42.25M
-149.57%-9.67M
39.79%-9.69M
42.28%-9.19M
Net income from continuing operations
-18.30%-26.95M
-63.22%-76.43M
-109.70%-23.58M
12.56%-14.12M
-66.46%-15.95M
-131.21%-22.78M
-30.19%-46.83M
-162.20%-11.24M
12.94%-16.15M
41.75%-9.58M
Operating gains losses
----
----
----
----
----
----
-98.79%61K
---3.39M
--5.94M
---2.39M
Depreciation and amortization
4.00%26K
12.36%100K
0.00%25K
4.17%25K
13.64%25K
38.89%25K
178.13%89K
116.34%25K
-58.62%24K
-64.52%22K
Other non cash items
69.05%142K
37.44%290K
-1,795.12%-1.39M
-43.90%46K
5,840.74%1.55M
13.51%84K
-86.47%211K
108.13%82K
156.25%82K
-172.97%-27K
Change In working capital
21.29%-10.88M
-238.96%-2.95M
34.98%5.22M
17,583.33%5.31M
-85.87%339K
-231.21%-13.82M
65.24%2.13M
23.22%3.87M
-95.74%30K
198.24%2.4M
-Change in prepaid assets
-352.86%-4.11M
-431.25%-1.17M
-173.84%-1.51M
24.56%213K
-22.40%1.04M
71.58%-908K
125.77%352K
-25.29%2.04M
120.70%171K
720.93%1.34M
-Change in payables and accrued expense
47.88%-6.69M
-185.45%-1.73M
252.32%6.69M
11,100.00%5.04M
-160.46%-633K
-1,231.33%-12.83M
-29.02%2.03M
10.40%1.9M
-96.26%45K
155.31%1.05M
-Change in other current assets
----
--0
--0
--0
----
----
200.00%64K
--0
--0
--0
-Change in other current liabilities
1.32%-75K
83.07%-54K
146.58%34K
127.96%52K
-476.47%-64K
1.30%-76K
-126.24%-319K
---73K
---186K
--17K
Cash from discontinued investing activities
Operating cash flow
5.26%-33.6M
-73.87%-73.46M
-84.13%-17.8M
22.86%-7.48M
-38.39%-12.72M
-158.86%-35.47M
-53.45%-42.25M
-149.57%-9.67M
39.79%-9.69M
42.28%-9.19M
Investing cash flow
Cash flow from continuing investing activities
-131.03%-67K
41.06%-89K
75.00%-3K
-136.84%-45K
40.00%-12K
71.00%-29K
-122.06%-151K
-71.43%-12K
-19K
-20K
Net PPE purchase and sale
-131.03%-67K
41.06%-89K
75.00%-3K
-136.84%-45K
40.00%-12K
71.00%-29K
-122.06%-151K
-71.43%-12K
---19K
---20K
Cash from discontinued investing activities
Investing cash flow
-131.03%-67K
41.06%-89K
75.00%-3K
-136.84%-45K
40.00%-12K
71.00%-29K
-122.06%-151K
-71.43%-12K
---19K
---20K
Financing cash flow
Cash flow from continuing financing activities
-79.43%15.9M
60.68%239.38M
-94.79%7.76M
1,990.91%460K
178,801.16%153.86M
140,456.36%77.31M
65.66%148.98M
244.86%148.82M
101.76%22K
105.44%86K
Net common stock issuance
-69.59%14.85M
272.11%199.08M
-87.01%6.95M
---100K
--143.4M
--48.82M
--53.5M
--53.5M
--0
--0
Proceeds from stock option exercised by employees
-96.31%1.05M
18,302.28%40.3M
1,339.29%806K
2,445.45%560K
12,052.33%10.45M
51,689.09%28.48M
222.06%219K
233.33%56K
--22K
-18.87%86K
Net other financing activities
----
----
----
----
----
----
--95.26M
----
----
----
Cash from discontinued financing activities
Financing cash flow
-79.43%15.9M
60.68%239.38M
-94.79%7.76M
1,990.91%460K
178,801.16%153.86M
140,456.36%77.31M
65.66%148.98M
244.86%148.82M
101.76%22K
105.44%86K
Net cash flow
Beginning cash position
85.13%360.62M
120.82%194.79M
566.05%370.66M
478.09%377.72M
217.72%236.6M
120.82%194.79M
240.77%88.21M
-63.00%55.65M
-61.06%65.34M
-59.81%74.47M
Current changes in cash
-142.49%-17.77M
55.60%165.83M
-107.22%-10.04M
27.12%-7.06M
1,646.00%141.12M
404.17%41.81M
70.99%106.58M
267.15%139.14M
44.34%-9.69M
47.87%-9.13M
End cash Position
44.91%342.85M
85.13%360.62M
85.13%360.62M
566.05%370.66M
478.09%377.72M
217.72%236.6M
120.82%194.79M
120.82%194.79M
-63.00%55.65M
-61.06%65.34M
Free cash flow
5.15%-33.67M
-73.46%-73.55M
-83.93%-17.8M
22.55%-7.52M
-38.22%-12.74M
-157.19%-35.5M
-53.62%-42.4M
-149.65%-9.68M
39.90%-9.71M
42.15%-9.21M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 5.26%-33.6M-73.87%-73.46M-84.13%-17.8M22.86%-7.48M-38.39%-12.72M-158.86%-35.47M-53.45%-42.25M-149.57%-9.67M39.79%-9.69M42.28%-9.19M
Net income from continuing operations -18.30%-26.95M-63.22%-76.43M-109.70%-23.58M12.56%-14.12M-66.46%-15.95M-131.21%-22.78M-30.19%-46.83M-162.20%-11.24M12.94%-16.15M41.75%-9.58M
Operating gains losses -------------------------98.79%61K---3.39M--5.94M---2.39M
Depreciation and amortization 4.00%26K12.36%100K0.00%25K4.17%25K13.64%25K38.89%25K178.13%89K116.34%25K-58.62%24K-64.52%22K
Other non cash items 69.05%142K37.44%290K-1,795.12%-1.39M-43.90%46K5,840.74%1.55M13.51%84K-86.47%211K108.13%82K156.25%82K-172.97%-27K
Change In working capital 21.29%-10.88M-238.96%-2.95M34.98%5.22M17,583.33%5.31M-85.87%339K-231.21%-13.82M65.24%2.13M23.22%3.87M-95.74%30K198.24%2.4M
-Change in prepaid assets -352.86%-4.11M-431.25%-1.17M-173.84%-1.51M24.56%213K-22.40%1.04M71.58%-908K125.77%352K-25.29%2.04M120.70%171K720.93%1.34M
-Change in payables and accrued expense 47.88%-6.69M-185.45%-1.73M252.32%6.69M11,100.00%5.04M-160.46%-633K-1,231.33%-12.83M-29.02%2.03M10.40%1.9M-96.26%45K155.31%1.05M
-Change in other current assets ------0--0--0--------200.00%64K--0--0--0
-Change in other current liabilities 1.32%-75K83.07%-54K146.58%34K127.96%52K-476.47%-64K1.30%-76K-126.24%-319K---73K---186K--17K
Cash from discontinued investing activities
Operating cash flow 5.26%-33.6M-73.87%-73.46M-84.13%-17.8M22.86%-7.48M-38.39%-12.72M-158.86%-35.47M-53.45%-42.25M-149.57%-9.67M39.79%-9.69M42.28%-9.19M
Investing cash flow
Cash flow from continuing investing activities -131.03%-67K41.06%-89K75.00%-3K-136.84%-45K40.00%-12K71.00%-29K-122.06%-151K-71.43%-12K-19K-20K
Net PPE purchase and sale -131.03%-67K41.06%-89K75.00%-3K-136.84%-45K40.00%-12K71.00%-29K-122.06%-151K-71.43%-12K---19K---20K
Cash from discontinued investing activities
Investing cash flow -131.03%-67K41.06%-89K75.00%-3K-136.84%-45K40.00%-12K71.00%-29K-122.06%-151K-71.43%-12K---19K---20K
Financing cash flow
Cash flow from continuing financing activities -79.43%15.9M60.68%239.38M-94.79%7.76M1,990.91%460K178,801.16%153.86M140,456.36%77.31M65.66%148.98M244.86%148.82M101.76%22K105.44%86K
Net common stock issuance -69.59%14.85M272.11%199.08M-87.01%6.95M---100K--143.4M--48.82M--53.5M--53.5M--0--0
Proceeds from stock option exercised by employees -96.31%1.05M18,302.28%40.3M1,339.29%806K2,445.45%560K12,052.33%10.45M51,689.09%28.48M222.06%219K233.33%56K--22K-18.87%86K
Net other financing activities --------------------------95.26M------------
Cash from discontinued financing activities
Financing cash flow -79.43%15.9M60.68%239.38M-94.79%7.76M1,990.91%460K178,801.16%153.86M140,456.36%77.31M65.66%148.98M244.86%148.82M101.76%22K105.44%86K
Net cash flow
Beginning cash position 85.13%360.62M120.82%194.79M566.05%370.66M478.09%377.72M217.72%236.6M120.82%194.79M240.77%88.21M-63.00%55.65M-61.06%65.34M-59.81%74.47M
Current changes in cash -142.49%-17.77M55.60%165.83M-107.22%-10.04M27.12%-7.06M1,646.00%141.12M404.17%41.81M70.99%106.58M267.15%139.14M44.34%-9.69M47.87%-9.13M
End cash Position 44.91%342.85M85.13%360.62M85.13%360.62M566.05%370.66M478.09%377.72M217.72%236.6M120.82%194.79M120.82%194.79M-63.00%55.65M-61.06%65.34M
Free cash flow 5.15%-33.67M-73.46%-73.55M-83.93%-17.8M22.55%-7.52M-38.22%-12.74M-157.19%-35.5M-53.62%-42.4M-149.65%-9.68M39.90%-9.71M42.15%-9.21M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg